Prescribing patterns and cost of antihypertensive drugs in an internal medicine clinic

Indian Heart Journal

Volumn 53, Issue 3, 2001, Pages 323-327

  Jhaj, Ratinder ^a   Goel, N K ^a   Gautam, C S ^a   Hota, D ^a   Sangeeta, B ^a   Sood, A ^a   Sachdev, A ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Cost benefit analysis; Drugs; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; DRUG UTILIZATION; ECONOMICS; FEMALE; HUMAN; HYPERTENSION; INDIA; INTERNAL MEDICINE; MALE; MIDDLE AGED; OUTPATIENT DEPARTMENT; STATISTICS; TEACHING HOSPITAL;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DRUG UTILIZATION; FEMALE; HOSPITALS, TEACHING; HUMANS; HYPERTENSION; INDIA; INTERNAL MEDICINE; MALE; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0035346399     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP - Hypertension). Lancet 1991; 338: 1281-1285
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program. JAMA 1991; 265: 3255-3264
3. Medical Research Council Working Party. MRC trial of treatment in mild hypertension: principal results. Br Med J (Clin Res Ed) 1985; 291: 97-104
4. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000; 342: 145-153
5. Manolio TA, Cutler JA, Furberg CD, Psaty BM, Whelton PK, Applegate WB. Trends in pharmacological management of hypertension in the United States. Arch Intern Med 1995; 155: 829-837
6. Seigel D, Lopez J. Trends in antihypertensive drug use in the United States. Do the JNC V recommendations affect prescribing? JAMA 1997; 278: 1745-1748
7. The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991; 151: 1413-1423
8. Grimm RH Jr, Grandits JA, Culler JA, Stewart AL, Mc Donald RH, Svendsen K, et al. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997; 157: 638-648
9. Wassertheil-Smoller S, Blaufox D, Oberman A, Davis BR, Swencionis C, Knerr MO, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med 1991; 114: 613-620
10. The Sixth Report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-2445
11. Current Index of Medical Specialities Volume 22: Bangalore: Bio-Gard Private Limited, Oct-Dec 1999
12. Indian Pharmaceutical Guide 37th ed, New Delhi: PamPosh Publication, 1999
13. Gupta R, al-Odat NA, Gupta VP. Hypertension epidemiology in India: meta-analysis of fifty-year prevalence rates and blood pressure trends. J Hum Hypertens 1996; 10: 465-472
14. Kalavathy MC, Thankappan KR, Sarma PS, Vasan RS. Prevalence, awareness, treatment and control of hypertension in an elderly community-based sample in Kerala, India. Natl Med J India 2000; 13: 9-15
15. Lee PK, Li RK, Chan JC, Chang S, Lee SG, Tomlinson B, et al. A prescription survey in a hospital hypertension outpatient clinic. Br J Clin Pharmacol 1997; 44: 577-582
16. Ramsay L, Williams B, Johnston G, MacGregor G, Poston L, Potten J, et al. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569-592
17. Xavier D, Rani N, Srishyla MV. Drug utilization study of antihypertensives and anti-diabetics in an Indian referral hospital. Indian J Pharmacol 1999; 31: 241-242
18. Gates JA. Antihypertensive agents and drug therapy of hypertension In: Hardman JG, Limbird LE, Mollnoff PB, Ruddon RW, Gilman AG (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw Hill 1996; pp. 780-808
19. Gress TW, Nieto, Shahar E, Wofford MR, Brancati FL Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000; 342: 905-912
20. UK Prospective Diabetes Study group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713-720